F-Dopa as an amino acid tracer to detect brain tumors

Journal of Nuclear Medicine

Volumn 37, Issue 7, 1996, Pages 1180-1182

  Heiss, W D ^a   Wienhard, K ^b   Wagner, R ^b   Lanfermann, H ^b   Thiel, A ^b   Herholz, K ^b   Pietrzyk, U ^b  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b NONE

Author keywords

brain tumor; carbon 11 methionine; fluorodeoxyglucose; magnetic resonance spectroscopy; oxygen 15 water; Parkinson's disease; PET, fluorine 18 Dopa

Indexed keywords

CARBON 11; CHOLINE; DOPA; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; LACTIC ACID; METHIONINE; N ACETYLASPARTIC ACID; OXYGEN 15;

ADULT; AMINO ACID METABOLISM; ARTICLE; ASTROCYTOMA; BASAL GANGLION; BRAIN METABOLISM; BRAIN TUMOR; CASE REPORT; DOPAMINE METABOLISM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GLUCOSE METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

BRAIN; BRAIN NEOPLASMS; DEOXYGLUCOSE; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLIOMA; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; METHIONINE; MIDDLE AGED; OXYGEN RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 0029740689     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Playford ED, Brooks DJ. In vivo and in vitro studies of the dopaminergic system in movement disorders. Cerebrovasc Brain Metab Rev 1992;4:144-171.
2. Mazoyer BM, Heiss W-D, Comar D. PET studies on amino acid metabolism and protein synthesis. Dordrecht: Kluwer; 1993.
3. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss W-D. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992;16: 804-813.
4. Nyberg P, Nordberg A, Wester P, et al. Dopaminergic deficiency is more pronounced in putamen than in nucleus caudatus in Parkinson's disease. Neurochemistry 1983;13: 12-18.
5. Nauta WJH. Neural association of the frontal cortex. Acta Neurobiol Exp 1972;32: 125-140.
6. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. TINS 1990;13:266-271.
7. Garnett ES, Lang AE, Chirakal R, et al. A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum. Can J Neurol Sci 1987;14:444-447.
8. 18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1987;22:360-371.
9. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer 1988;62:1074-1078.
10. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991;32:616-622.
11. Herholz K, Rudolf J, Heiss W-D. FDG transport and phosphorylation in human gliomas measured with dynamic PET. J Neuro Oncol 1992;12:159-165.
12. Herholz K, Pietrzyk U, Voges J, et al. Correlation of glucose consumption and tumor cell density in astrocytomas: a stereotactic PET study. J Neurosurg 1993;79:853-858.
13. Patronas NJ, Di Chiro G, Kufta C, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985;62:816-822.
14. Hoelzer T, Herholz K, Jeske J, Heiss W-D. FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 1993;17:681-687.
15. Mineura K, Sasajima T, Kowada M, et al. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994;73:2386-2394.
16. 11C-L-methionine PET. J Nucl Med 1986;27:890-891.
17. 68Ga-EDTA in supratentorial tumors. J Comput Assist Tomogr 1985;9:683-689.
18. Derlon JM, Bourdet C, Bustany P, et al. Carbon-11-methionine uptake in gliomas. Neurosurgery 1989;25:720-728.
19. 18F]fluorotyrosine. J Nucl Med 1991;32:1338-1346.
20. 11C-methyl-L-methionine uptake index. Neurol Med Chir (Tokyo) 1990;30:997-1002.
21. Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature 1983;305:137-138.
22. 18F]fluoro-3,4-dihydroxyphenylalanine in primate. J Neurochem 1987;48:1077-1082.
23. Leenders KL, Palmer AJ, Quinn N, et al. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry 1986;49:853-860.
24. 18F-Dopa positron emission tomography studies in an Irish kindred. Ann Neurol 1992;32:609-617.
25. Vingerhoets FJG, Snow BJ, Tetrud JW, Langston JW, Schulzer M, Calne DB. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 1994;36:765-770.